$NAOV News

Last published 8mo ago

8mo agoFEED NAOVENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal CameraGlobeNewswireTYLER, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a leader in advanced navigation technologies for enteral access, today announced that the
9mo agoFEED NAOVENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe LineGlobeNewswireTYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent,
9mo agoFEED NAOVENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, CommercialGlobeNewswireTYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent,
10mo agoFEED NAOVENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a PrescriptionGlobeNewswireTYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent,
10mo agoFEED NAOVENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical ResearchGlobeNewswireTYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing on the advancement of intelligent,
10mo agoFEED NAOVENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026GlobeNewswireTYLER, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems
10mo agoFEED NAOVENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UKGlobeNewswireTYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in non-invasive therapeutic
10mo agoFEED NAOVENvue Medical's UroShield® Kit Secures Reimbursement in the UKGlobeNewswireTYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today
11mo agoNAOVNanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and 'FEED'Business WireNew ticker symbol, "FEED" will begin trading on the Nasdaq at the open of the market on December 12, 2025 NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in
11mo agoNAOVNanoVibronix Issues Letter to ShareholdersBusiness WireENvue® Feeding Tube Placement System Identified as Core Growth Platform Strategic Rebranding and Name Change to Reflect Company's Focus on Multi-Billion-Dollar Enteral-Feeding Market The Company is Considering
1y agoNAOVNanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced that it has entered into a definitive agreement with a
1y agoNAOVNanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property PortfolioBusiness WireLatest patent award strengthens competitive moat and reinforces leadership in medical navigation technology NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing
1y agoNAOVNanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation TechnologyBusiness WirePatent strengthens company's leadership in feeding tube placement and opens path to broader vascular navigation market NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company
1y agoNAOVNanoVibronix Announces Reverse Stock SplitBusiness WireCommon Stock Will Begin Trading on Split-Adjusted Basis on August 12, 2025 NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic
1y agoNAOVNanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred StockBusiness WireUpfront $8 Million in Gross Proceeds and potential $40 million in Gross Proceeds from Exercise of Additional Investment Rights NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology
1y agoNAOVNanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line NavigationBusiness WireENvue Targeting $10 Billion+ Market Opportunity with Scalable AI-Enhanced Clinical Robotics NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive
1y agoNAOVNanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube PlacementBusiness WireDual-System Agreement Highlights Transition Towards Advanced Bedside Navigation NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic
1y agoNAOVENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance SystemBusiness WirePatent strengthens ENvue's IP position as it advances toward pediatric regulatory clearance and expanded clinical use NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company
1y agoNAOVNanoVibronix Announces CEO TransitionBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in therapeutic devices, today announced the retirement of Brian Murphy as Chief Executive Officer, effective
1y agoNAOVNanoVibronix Responds to False PostBusiness WireNanoVibronix, Inc. (the "Company") (NASDAQ:NAOV) confirmed that a series of posts made earlier today with respect to a $26 million registered direct offering of common stock of the Company priced at $0.45 under Nasdaq
1y agoNAOVMajor Louisiana Hospital Selects ENvue System for Feeding Tube ProceduresBusiness WireGreater New Orleans Area Facility to Transition from Blind Insertions to FDA-Cleared Electromagnetic Guidance NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company
1y agoNAOVNanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and WarrantsBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in therapeutic devices, today announced the closing of its previously announced underwritten public offering
1y agoNAOVNanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and WarrantsBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in therapeutic devices, today announced the pricing of an underwritten public offering of approximately
1y agoNAOVNanoVibronix Announces Results from UroShield™ Case SeriesBusiness WireUroShield Demonstrates Significant Reductions in CAUTIs, Catheter Blockages and Hospital Visits NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical technology company specializing in therapeutic devices, today
1y agoNAOVNanoVibronix Regains Nasdaq ComplianceBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) (the "Company" or "NanoVibronix"), a medical technology company specializing in non-invasive therapeutic devices, today announced that on April 9, 2025, Nasdaq formally notified the
1y agoNAOVNanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in AustraliaBusiness WirePublication of Independent Study Heightens Demand for UroShield NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company" or "NanoVibronix"), a medical technology company specializing in non-invasive therapeutic devices, today
1y agoNAOVSuccessful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence JournalBusiness WireUroShield Cited as Effective in Preventing CAUTIs and Blockages, Having a Major Impact on Quality of Life and Reducing Healthcare Resource Costs NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical technology
1y agoNAOVNanoVibronix Announces Reverse Stock SplitBusiness WireCommon Stock Will Begin Trading on Split-Adjusted Basis on March 14, 2025 NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic
1y agoNAOVNanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.Business WireNanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion of the acquisition of ENvue Medical Holdings Corp.
1y agoNAOVNanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen PrototypesBusiness WireDevelopment advancing to verification and testing phase; Aims to future-proof design, lower componentry costs and improve manufacturing NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical device company that
1y agoNAOVNanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of MichiganBusiness WireResearch expected to advance to ‘Full Study' phase in 2025 NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface
1y agoNAOVNanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution AgreementBusiness WireExtends Relationship with Ultra Pain Products, Inc for Distribution of PainShield for Five Years NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®,
1y agoNAOVNanoVibronix Provides Business UpdateBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices,
2y agoNAOVNanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in GermanyBusiness WireSigns Term Sheet for a License and Supply Agreement for Distribution of UroShield NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and
2y agoNAOVNanoVibronix Signs Letter of Intent with Potential New DistributorBusiness WireNanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices,
2y agoNAOVNanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a
2y agoNAOVNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced
2y agoNAOVNanoVibronix Issues Letter to StockholdersBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a
2y agoNAOVNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldBusiness WireNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic
2y agoNAOVNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract AwardBusiness WireDistribution Partner, Delta Medical, Awarded a Five-Year Federal Supply Schedule Contract for PainShield by Department of Veterans Affairs NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix," or the "Company"), a medical
2y agoNAOVNanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024ACCESS Newswire1x1 Meetings on Thursday, May 2, 2024ELMSFORD, NY / ACCESSWIRE / April 24, 2024 / NanoVibronix, Inc. , a medical device company that produces the
2y agoNAOVNanoVibronix Issues Letter to StockholdersBusiness WireNanoVibronix, Inc., (NASDAQ:NAOV)("NanoVibronix"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices,
2y agoNAOVNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldBusiness WireEfforts Focused on Adding Therapeutic Functionality and Reducing Costs NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield®, PainShield®
2y agoNAOVNanoVibronix Featured in Your Bladder Health MagazineBusiness WireUroShield Cited as Effective in Preventing CAUTIs and Blockages and Having a Major Impact on Quality of Life NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield®,
2y agoNAOVNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityBusiness WireIndependent Urology Company to Study the Potential for UroShield Distribution in Germany and other European Markets NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®,
2y agoNAOVNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganBusiness WireGathering Additional Clinical Evidence to Support Application to FDA for Permanent Clearance NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and
2y agoNAOVNanoVibronix Regains Nasdaq ComplianceBusiness WireNanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced
2y agoNAOVNanoVibronix Issues Letter to ShareholdersBusiness WireNanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a
3y agoNAOVNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1Business WireReceives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and
3y agoNAOVNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug TariffBusiness WireEstablishes Reimbursement for UroShield Actuators Enabling Increased Distribution to NHS Patients NHS Supply Chain Contract Extended for Complete UroShield System NanoVibronix, Inc. (Nasdaq: NAOV), a medical device